Chemistry:ADMB-3TMS-PRINACA
From HandWiki
ADMB-3TMS-PRINACA (ADB-3TMS-PRINACA) is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first identified in Germany in March 2023. It is the first designer drug ever reported that contains a silicon atom.[1]
Legality
ADMB-3TMS-PRINACA is illegal in Germany and Italy.[2]
See also
- ADB-PINACA
- ADB-FUBINACA
- CUMYL-3TMS-PRINACA
- 1S-LSD
- Silandrone
References
- ↑ "New psychoactive substances - the current situation in Europe". European Drug Report. European Union Drugs Agency (EUDA). 2024. https://www.euda.europa.eu/sites/default/files/pdf/31883_en.pdf?606797.
- ↑ "Notizie dalla FNOMCeO" (in it). Order of Surgeons and Dentists of the province of Brescia. https://www.ordinemedici.brescia.it/archivio10_notizie-e-comunicati_5_3153_994_9.html. "Update of the tables containing the indication of narcotic and psychotropic substances. Inclusion in Table I of the specific indication of the substances: 2'-fluoro-2-fluoro-3-methylfentanyl; N-cyclohexyl butylone; ADMB-3TMSPrinaca"
| Receptor (ligands)</small> |
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (modulators) |
| ||||||||||||
| Enzyme (modulators) |
| ||||||||||||
| Others |
| ||||||||||||
| |||||||||||||
 | 0.00  (0 votes) |
